Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
2/7/2025
AstraZeneca Reports Strong 2024 Performance Amid China Sales Decline a...
2/7/2025
NMPA Announces Package Insert Revision of Gemifloxacin Mesylate Tablet...
2/7/2025
Henlius Biotech's Lung Cancer Drug Secures EU Approval
2/7/2025
Henlius and Dr. Reddy's Ink Licensing Deal for Daratumumab Biosimilar ...
2/7/2025
Recent Executive Moves
2/7/2025
Chinese Biotech Firms Cash In On Promising Drug Discoveries Via Licens...
2/7/2025
Rapid Trials Prompt Deals Rush for Chinese ‘Super Me-Too’ Drugs (FT)
2/7/2025
China's Biopharma Mirrors EV Success (The China Academy)
2/6/2025
Merck Halts HPV Vaccine Supply: What It Says about China Market (EGGI)
2/5/2025
Trump's Tariffs Threaten Big Pharma With Higher Costs and Slimmer Marg...
2/5/2025
NH Reports Latest Data on Chinese Smoking Control Market in MAT 09/202...
2/5/2025
MediLink's YL217 received FDA Clearance of IND Application
2/5/2025
Merck Faces Growing Challenges in China as Gardasil Sales Stall
2/5/2025
Pfizer Eyes Expansion in China Amid Pipeline Reshuffle
2/2/2025
I-Mab Cuts 27% of Workforce Amid Strategic Shift
2/2/2025
FDA Approves XellSmart's IND for iPSC-Derived Cell Therapy in Parkinso...
2/2/2025
BeiGene Launches Phase 1 Trial for CLDN6/CD3 BsAb BGB-B455 in Solid Tu...
2/2/2025
FDA Approves Minwei Biotech's IND for MWN105
2/2/2025
ImmunityBio and BeiGene Partner on Phase 3 Trial of ANKTIVA and PD-1 I...
1/28/2025
CStone Partners with SteinCares to Market Sugemalimab in Latin America
1/28/2025
China's Evolving Role in Pharma Spurs Regional Realignments, Boosts In...
1/28/2025
Akeso's Gumokimab Advances Toward Approval in China for Plaque Psorias...
1/28/2025
Exploring Biopharma's Dealmaking Terrain, Roadmap in China (PharmExec)
1/27/2025
Lumiere Secures Series Pre-A Funding to Advance Gene Editing Research
1/27/2025
GeneQuantum Announces Strategic Collaborations with Biohaven and Aimed...
1/27/2025
State Council Releases Final Antitrust Guidelines for the Pharmaceutic...
1/27/2025
NHSA Issues Two New Documents on DRG Payment Management
1/24/2025
NHSA Solicits Information on Low-Transaction Drugs in the National Dru...
1/24/2025
Snapshot of BMI System Financial Performance in 2024
1/24/2025
Recent Executive Moves
Page:
7
/
354
Total number of articles:
10618
:
[First]
[<<]
[5]
[6]
[7]
[8]
[9]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit